Global Biomaterials Market

Biomaterials Market Size, Share, Growth Analysis, By Type(Metallic, Polymeric, Ceramic, and Natural), By Application(Cardiovascular, Dental, Orthopedic, Wound Healing), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2027 | Region: Global | Published Date: August, 2024
Pages: 157 | Tables: 69 | Figures: 75

Biomaterials Market Insights

Global Biomaterials Market size was valued at USD 135.4 Billion in 2022 poised to grow from USD 155.9 Billion in 2023 to USD 438.1 Billion by 2031, growing at a CAGR of 15.4% in the forecast period (2024-2031). 

Due to factors such as an older demographic, higher incidence rates of heart disease and joint problems, advancing healthcare technologies, and escalating public knowledge about devices that can be implanted in people’s bodies, there is significant growth in the global biomaterials market. This growth can also be attributed to increased government backing for biomaterials research and development along with heightened consumer comprehension regarding the merits associated with products made using biomaterials. Nevertheless, it is foreseen that compatibility challenges and the expensive nature of biomaterial implants could restrain growth of the market. 

However, the introduction of new technologies—decellularized dermal matrixes for grafting and hydrogen scaffolding, for example—as well as new products in the fields of neurology, wound healing, and plastic surgery are anticipated to present lucrative growth opportunities for the market over the course of the forecast period. The goal of implantable biomaterials is to reduce the adverse immune response while maintaining proper function, as the body cannot fully integrate any foreign substance to enhance its biological functions. For the purpose of treating neurological, orthopaedic, dental, and cardiovascular disorders, among other medical conditions, these biomaterials interact with biological systems.

US Biomaterials Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Biomaterials Market size was valued at USD 135.4 Billion in 2022 poised to grow from USD 155.9 Billion in 2023 to USD 438.1 Billion by 2031, growing at a CAGR of 15.4% in the forecast period (2024-2031). 

Leading businesses in the fiercely competitive global biomaterials market prioritise innovation, product development, and strategic alliances. Medtronic, Stryker Corporation, Johnson & Johnson, Zimmer Biomet alongside DSM Biomedical happen to be major players in this field. These companies have retained their top positions because of their diversified range of modern biomaterials, global distribution channels and aggressive research and development initiatives. An additional competition driver is from start-ups and entrants particularly in fast growing markets like Asia Pacific. 'BASF SE (Germany) ', 'Covestro AG (Germany) ', 'Celanese Corporation (US) ', 'Carpenter Technology Corporation (US) ', 'DSM (Netherlands) ', 'Corbion NV (Netherlands) ', 'Evonik Industries AG (Germany) ', 'Victrex Plc (UK) ', 'CeramTec GmbH (Germany) ', 'Mitsubishi Chemical Group Corporation (Japan) ', 'CoorsTek Inc. (US) ', 'Berkeley Advanced Biomaterials (US) ', 'CAM Bioceramics B.V. (Netherlands) ', 'Zeus Company Inc. (US) ', 'AMETEK Inc. (US) ', 'GELITA AG (Germany)'

Wound healing and plastic surgery are two common applications for biomaterial-based products. Biomaterials are frequently used in plastic surgery to implant, reconstruct, heal, and conceal burns, holes in the body, or soft tissue injuries in a natural and safe manner. One major factor driving the medical industry is the increase in demand for biomaterials in plastic surgery and wound healing. 

Growing Requirement in Medical Applications for Biodegradable Biomaterials: Global biomaterials market is witnessing an increase in trend on the demand of biodegradable materials due to its use in tissue engineering, wound healing and drug delivery. Preference for these materials arises from their ability to break down within the body safely hence reducing follow-up procedures and improving the health of patients. 

Due to its sophisticated healthcare system, significant R&D spending, and strong concentration of important industry participants, North America leads the global biomaterials market. Large government investment for medical research is beneficial to the region, especially for biomaterials used in orthopedic and cardiovascular applications. In addition, there is a growing need for novel biomaterial-based therapies due to the ageing population and the rise in chronic illness. This industry is being pushed forward through favorable regulatory environments and quick clearance procedures. The North American region's position as a global frontrunner in biomaterial market is also supported by the United States' lead in technological advancements, as well as the use of modern medical equipment. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Biomaterials Market

Report ID: SQMIG35H2027

$5,300
BUY NOW GET FREE SAMPLE